{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:34:52Z","timestamp":1788352492961,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009584","name":"Toyota Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008262","name":"Harboe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010347","name":"Manufacturer Einar Willumsens Memorial Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009906","name":"Wholesaler A V Lykfeldt and Wife's Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009906","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004331","name":"Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009457","name":"Region Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019854","name":"Greater Copenhagen Health Science Partners","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109236","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:53:16Z","timestamp":1733471596000},"page":"109236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation"],"prefix":"10.1016","volume":"245","author":[{"given":"Marie Hvelplund","family":"Kristiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Kranker","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Massarenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Enevold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels","family":"Wienecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.thromres.2024.109236_bb0005","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms. Longo DL, editor","volume":"376","author":"Spivak","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2024.109236_bb0015","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1038\/s41375-021-01159-8","article-title":"Early detection of myeloproliferative neoplasms in a Danish general population study","volume":"35","author":"Cordua","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.thromres.2024.109236_bb0020","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jjcc.2022.02.001","article-title":"Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F","volume":"81","author":"Misaka","year":"2023","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.thromres.2024.109236_bb0035","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1182\/bloodadvances.2023010588","article-title":"JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study","volume":"7","author":"Kristiansen","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2024.109236_bb0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3324\/haematol.12970","article-title":"Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain","volume":"93","author":"Ziakas","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clml.2018.08.020","article-title":"Influence of blood count, cardiovascular risks, inherited thrombophilia, and JAK2 V617F burden allele on type of thrombosis in patients with Philadelphia chromosome negative myeloproliferative neoplasms","volume":"19","author":"Horvat","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"26","key":"10.1016\/j.thromres.2024.109236_bb0050","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an international prognostic score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2024.109236_bb0055","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/cam4.2886","article-title":"Thrombosis among 1537 patients with JAK2V617F-mutated myeloproliferative neoplasms: risk factors and development of a predictive model","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.thromres.2024.109236_bb0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41375-021-01170-z","article-title":"Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms","volume":"35","author":"Guy","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.thromres.2024.109236_bb0065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2024.109236_bb0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00277-007-0386-3","article-title":"Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis","volume":"87","author":"Alvarez-Larr\u00e1n","year":"2008","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109236_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.22264","article-title":"Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment-flow cytometry and soluble E-selectin detection","volume":"87","author":"Belotti","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"13","key":"10.1016\/j.thromres.2024.109236_bb0080","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","article-title":"Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera","volume":"96","author":"Falanga","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2024.109236_bb0085","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/s41375-019-0500-2","article-title":"High circulating levels of MPO-DNA are associated with thrombosis in patients with MPN","volume":"33","author":"Guy","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0090","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.thromres.2024.109236_bb0095","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-164087","article-title":"Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera","volume":"112","author":"Marchetti","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK 2 V617F allele burden","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0105","article-title":"Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation. Res Pract","volume":"7","author":"Guy","year":"2023","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.21338","article-title":"Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden","volume":"84","author":"Arellano-Rodrigo","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/bjh.18845","article-title":"Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms","volume":"202","author":"Massarenti","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"436","key":"10.1016\/j.thromres.2024.109236_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"August","key":"10.1016\/j.thromres.2024.109236_bb0125","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/STROKEAHA.121.034388","article-title":"Inflammation and stroke risk: a new target for prevention","author":"Kelly","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.109236_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.thromres.2024.109236_bb0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOH.0000000000000664","article-title":"Thrombosis in myeloproliferative neoplasms: update in pathophysiology","volume":"28","author":"Reeves","year":"2021","journal-title":"Curr. Opin. Hematol."},{"issue":"May","key":"10.1016\/j.thromres.2024.109236_bb0140","first-page":"1","article-title":"Mutations, inflammation and phenotype of myeloproliferative neoplasms","volume":"13","author":"Hermouet","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.hoc.2020.11.003","article-title":"The microenvironment in myeloproliferative neoplasms","volume":"35","author":"Ramanathan","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.thromres.2024.109236_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000371","article-title":"Longitudinal cytokine profiling identifies GRO-\u03b1 and EGF as potential biomarkers of disease progression in essential thrombocythemia","volume":"4","author":"\u00d8bro","year":"2020","journal-title":"HemaSphere"},{"issue":"3","key":"10.1016\/j.thromres.2024.109236_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000407","article-title":"Cytokine profiling as a novel complementary tool to predict prognosis in MPNs?","volume":"4","author":"Hasselbalch","year":"2020","journal-title":"HemaSphere"},{"issue":"85","key":"10.1016\/j.thromres.2024.109236_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and myeloproliferative neoplasms","volume":"2017","author":"Lussana","year":"2017","journal-title":"J. Autoimmun."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2024.109236_bb0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2009.06.019","article-title":"Plasma levels of inflammatory and thrombotic\/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site","volume":"215","author":"Tuttolomondo","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.thromres.2024.109236_bb0170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.thromres.2024.109236_bb0175","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.109236_bb0180","author":"R Core Team"},{"key":"10.1016\/j.thromres.2024.109236_bb0185","author":"Wei"},{"issue":"07","key":"10.1016\/j.thromres.2024.109236_bb0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-09-0663","article-title":"Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms","volume":"104","author":"Cella","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100060","article-title":"Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation","volume":"7","author":"Guy","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2024.109236_bb0200","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1538-7836.2007.02626.x","article-title":"Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7F status, clonality, and antiphospholipid antibodies","volume":"5","author":"Robertson","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cardiores.2005.02.020","article-title":"Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3","volume":"67","author":"Singh","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2024.109236_bb0210","series-title":"Antioxidants and Redox Signaling","first-page":"1607","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"vol. 15","author":"Cook-Mills","year":"2011"},{"key":"10.1016\/j.thromres.2024.109236_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083850","article-title":"Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches","volume":"22","author":"Medina-Leyte","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2024.109236_bb0220","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes","volume":"96","author":"Schmidt","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.109236_bb0225","series-title":"Angiology","first-page":"397","article-title":"Novel biomarkers for evaluation of endothelial dysfunction","volume":"vol. 71","author":"Leite","year":"2020"},{"key":"10.1016\/j.thromres.2024.109236_bb0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","article-title":"Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thr","volume":"117","author":"Alexander","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2024.109236_bb0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/07853890701854702","article-title":"Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction","volume":"40","author":"M\u00fcnzel","year":"2008","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2003.07.014","article-title":"Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis","volume":"96","author":"G\u00fcray","year":"2004","journal-title":"Int. J. Cardiol."},{"issue":"14","key":"10.1016\/j.thromres.2024.109236_bb0245","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/euhj.1999.1451","article-title":"Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction","volume":"20","author":"Wall\u00e9n","year":"1999","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0250","first-page":"57","article-title":"Soluble levels of cell adhesion molecules (CAMs) in coronary artery disease","volume":"62","author":"Mashru","year":"2010","journal-title":"Indian Heart J."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2024.109236_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000006995","article-title":"Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease","volume":"93","author":"Semaan","year":"2000","journal-title":"Cardiology"},{"issue":"4","key":"10.1016\/j.thromres.2024.109236_bb0260","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer","volume":"19","author":"Kong","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01780-x","article-title":"KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke","volume":"17","author":"Zhang","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.thromres.2024.109236_bb0270","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/hc3701.095949","article-title":"Circulating cell adhesion molecules and death in patients with coronary artery disease","volume":"104","author":"Blankenberg","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archneur.63.1.noc50221","article-title":"Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease","volume":"63","author":"Campbell","year":"2006","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0280","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood-2012-01-404889","article-title":"Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation","volume":"121","author":"Rosti","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2024.109236_bb0285","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2010-07-297598","article-title":"Endothelial progenitor cells are clonal and exhibit the JAK2 V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms","volume":"117","author":"Teofili","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0290","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2018.195321","article-title":"Vascular endothelial cell expression of JAK2 V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"104","author":"Guy","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.thromres.2024.109236_bb0295","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.109236_bb0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-\u03b1 in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin. Sci."},{"issue":"24","key":"10.1016\/j.thromres.2024.109236_bb0305","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2024.109236_bb0310","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/eji.200636012","article-title":"Interleukin-10 derived from macrophages and\/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA","volume":"36","author":"Siewe","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0315","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the Interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2024.109236_bb0320","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.4049\/jimmunol.1201103","article-title":"Activated platelets enhance IL-10 secretion and reduce TNF-\u03b1 secretion by monocytes","volume":"191","author":"Gudbrandsdottir","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.thromres.2024.109236_bb0325","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.leukres.2012.07.009","article-title":"Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance","volume":"36","author":"Skov","year":"2012","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0330","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/bloodadvances.2018026450","article-title":"Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-a in myeloproliferative neoplasm","volume":"3","author":"Lai","year":"2019","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.atherosclerosis.2008.06.030","article-title":"Immuno-inflammatory and thrombotic\/fibrinolytic variables associated with acute ischemic stroke diagnosis","volume":"203","author":"Tuttolomondo","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/000331970605700212","article-title":"Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects","volume":"57","author":"Marketou","year":"2006","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.thromres.2024.109236_bb0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1747493020971104","article-title":"Frequency and predictors of occult cancer in ischemic stroke: a systematic review and meta-analysis","volume":"16","author":"Rioux","year":"2021","journal-title":"Int. J. Stroke"},{"issue":"15","key":"10.1016\/j.thromres.2024.109236_bb0350","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.2023022260","article-title":"Jak2V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk","volume":"143","author":"Liu","year":"2024","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2024.109236_bb0355","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2023-188000","article-title":"Platelet-restricted clonal hematopoiesis","volume":"142","author":"Sousos","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2024.109236_bb0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.thromres.2024.109236_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI180066","article-title":"Clonal hematopoiesis and atherosclerosis","volume":"134","author":"Oren","year":"2024","journal-title":"J. Clin. Invest."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:46Z","timestamp":1735238026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":73,"alternative-id":["S0049384824003682"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109236","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109236"}}